| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.042 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |